Submit your Product Liability claim details for a free, no obligation case review.
Get Started:
product_liability MedtronicMedtronic Inc. is the largest maker of implantable cardioverter defibrillators (ICDs) and pacemakers. On February 11, 2005, the FDA announced Medtronic was issuing a safety warning because of a potential battery shorting mechanism that could occur in some of its ICD devices. According to the notification letter sent to physicians, the company reported that nine batteries experienced rapid battery depletion due to the shorting action among the Medtronic defibrillators. The danger among shorting Medtronic defibrillators is that it could cause the battery to deplete within a few hours to a few days, resulting in a complete loss of device function.
Affected Medtronic defibrillators included devices manufactured between April 2001 and December 2003 in subsets of:
Roughly 75 percent of the potentially defective Medtronic defibrillators were implanted in the United States. The Medtronic defibrillator warnings came as the industry was pushing to increase the number of implants after a study showed 80 percent of heart patients who could benefit from ICDs do not have one.
After a series of defibrillator and heart device recalls and safety warnings, the Public Citizen consumer group petitioned the FDA to change the current system, allowing companies to delay the removal of a flawed device. Doctors continue to use the remaining inventory despite changes in flawed devices in order to deplete inventory of older, defective devices, and problems among Medtronic defibrillators, as well as Guidant Corp. and St. Judge Medical Inc.’s devices – the number two and three makers of ICDs, was evidence, according to the consumer group, of company profits being put ahead of patient safety.
Defibrillators are special medical implants with significant lifesaving capabilities. Therefore, when a defect is present, the results can be devastating. The FDA has been criticized for failing to require special oversight of the essential medical devices, allowing the majority to be placed on the market without requiring clinical testing as long as they were “substantially equivalent” to previously marketed devices.
In 2005, after the top three defibrillator manufacturers issued massive recalls and safety warnings, two U.S. lawmakers said they planned on increasing scrutiny of the FDA and its processes because of “FDA incompetence and a lack of diligence,” according to U.S. Rep. Edward Markey.
Contact a product liability lawyer for more information on the Medtronic defibrillators recall.
Medtronic, the world’s largest maker of implantable cardioverter defibrillators (ICDs), has agreed to settle 2,682 product liability lawsuits for $95.6 million.
Marquis ICDs
The lawsuits were filed in connection ...
The Supreme Court heard arguments in a controversial case involving a defective heart catheter made by Medtronic on Tuesday. At issue is whether or not the manufacturer can be held liable under state law for the plaintiff’s injuries since the dev...
A vital wire in certain implanted heart devices may falter and cause serious injury, possibly even death, according to an announcement made by the Food and Drug Administration on Monday. The defect has prompted the maker of the part to issue a voluntar...
FDA Press Release: Medtronic Issues Notification Regarding Certain Implantable Defibrillator Models
Statement on Medtronic's Voluntary Marketing Suspension of Their Sprint Fidelis Defibrillator Leads
Medtronic Voluntarily Suspends Distribution Of Sprint Fidelis® Defibrillation Leads